CD69 and systemic sclerosis: A study of NK cell frequency and function in SSc patients’ blood demonstrated a significant increase in NK cell numbers in dcSSc relative to controls, and increased expression of cell surface activation markers CD16 and CD69 on both lcSSc and dcSSc NK populations (Horikawa et al., 2005).